Interplay between pathologies of ovarian cancer and genomics
15 Nov 2012
Interplay between pathologies of ovarian cancer and genomics
Biology of molecular sub types in ovarian cancer
Sub-typing ovarian cancer
Early stage biomarkers in ovarian cancer
Drug approval process for ovarian cancer
Interaction between tumour biology and surgery
Collaborations in clinical trials to bring new drugs to patients earlier
Therapeutic exercise for patients with advanced cancer
Inequalities in cancer incidence, mortality and survival
Development of future cancer treatments
Tissue donation and clinical trials
Drug susceptibility in cancer cell lines